Biocon
Babu Gowda is an experienced professional in the biopharmaceutical industry, currently serving as an Executive at Biocon since August 2023. Previously, Babu worked as a QC Analytical Chemist at Stelis Biopharma from June 2021 to June 2023, expressing satisfaction in the initial role as a fresher. Babu holds a Master of Science in Inorganic Chemistry from Bengaluru Central University (2018-2020) and a Bachelor of Science in Physics, Chemistry, and Mathematics from AES National College (2015-2018). Babu's educational foundation is further complemented by studies at BGS PU College from 2013 to 2015.
This person is not in any teams
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.